Comparing Safety and Tolerability of Antipsychotic Treatment

Article Abstract

Certain modifiable risk factors for diabetes andcardiovascular disease need to be considered when prescribing antipsychoticmedications. Antipsychotics may change a patient’s weight, glucose,cholesterol, and triglycerides. These changes may lead to changes incardiopulmonary health. If switching medications is not a viable option, themetabolic and cardiopulmonary risks may be minimized by monitoring certainbehaviors such as smoking, exercise, diet, and medication adherence. Theprincipals of primary prevention suggest the importance of lowering risk fordisease by using monitoring and intervention approaches.

This CME activity is expired. For more CME activities, visit cme.psychiatrist.com.
Find more articles on this and other psychiatry and CNS topics:
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders

Volume: 68

Quick Links: Psychotic Disorders , Schizophrenia and Schizoaffective Disorders

Continue Reading…

Subscribe to read the entire article

$40.00

Buy this Article as a PDF

References